John D. Shakow
John Shakow focuses on complex regulatory, commercial, investigation, and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in King & Spalding’s FDA and Life Sciences practice and co-chair of the firm’s Life Sciences & Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation. He has counseled manufacturer clients on their rights and obligations under the Medicaid, 340B, Medicare, Federal Supply Schedule, and TRICARE programs for over 25 years.
